ISLAMABAD: The World Health Organization (WHO) in collaboration with the Drug Regulatory Authority of Pakistan (DRAP) has trained 50 experts from federal and provincial authorities to strengthen regulatory practices for the licensing of establishments and safe storage and distribution of medical products.
According to official sources, the training aimed to enhance participants’ understanding of good regulatory practices and ensure that medical products available in the country meet established safety and quality standards.
The programme focused on improving procedures for licensing relevant establishments and reinforcing good storage and distribution practices to maintain the quality, safety and integrity of medicines and other medical products throughout the supply chain.
Experts from federal and provincial regulatory authorities participated in the initiative, which sought to strengthen institutional capacity and promote consistent implementation of regulatory requirements across the country.
The collaboration reflects ongoing efforts by WHO and DRAP to improve the national regulatory system and ensure that medical products reaching patients are safe, effective and of assured quality, they said.